EUVIMEDEUVIMED entdecken
Crossref

Real-world systemic antibiotic prescribing patterns in hidradenitis suppurativa: a multicentre international observational study

Elia Rosi, Gianmarco Silvi, Antonella Di Cesare, Piotr K Krajewski, Jacek Szepietowski, Ariany T.A.S. Denofre, Renata Ferreira Magalhães, Vincenzo Bettoli, Claudio Pelucchi, Carlotta Galeone, Francesca Prignano

Dermatology · 05.11.2026

DOI: 10.1159/drm/ackag033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology, online erschienen am 05.11.2026. Verfasst von Elia Rosi und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder. Systemic antibiotics remain widely prescribed for HS despite limited evidence supporting prolonged or repeated courses and substantial variability in prescribing practices across healthcare settings. This variability underscores the importance of antimicrobial stewardship (AMS) principles as a conceptual framework for promoting more rational antibiotic use in HS, although their implementation in routine clinical practice remains insufficiently characterized. This multicentre observational study aimed to describe real-world systemic antibiotic prescribing patterns in HS and explore factors associated with clinical outcomes and antibiotic discontinuation.

Methods

A retrospective observational study was conducted across academic centres in Italy, Poland, and Brazil. Patients with HS who had received at least one course of antibiotic therapy between December 2023 and December 2024 were included. Primary endpoints included antibiotic prescribing frequency, therapy discontinuation rates, and achievement of IHS4-55. Statistical analyses were performed to identify factors associated with the study outcomes.

Results

A total of 126 patients (mean age 37.0 ± 14.9 years, 57.1% female) were analysed. Doxycycline was the most prescribed antibiotic (24.6%), followed by trimethoprim-sulfamethoxazole (19.0%) and clindamycin (18.2%). The proportion of patients achieving IHS4-55 after the first antibiotic course was 34.1%, increasing to 37.3% after the second course. Severe HS (IHS4 ≥11) and pubic involvement were associated with lower likelihood of achieving IHS4-55 following an antibiotic course. Premature antibiotic discontinuation occurred in 12.7% of first-course patients, primarily due to adverse events (6.3%) and lack of effectiveness (4.8%).

Conclusion

This multicentre study provides real-world data on antibiotic prescribing in HS. Lower rates of IHS4-55 were observed among patients with severe disease and pubic involvement, while the marked heterogeneity of prescribing practices highlights the need for more evidence-based integration of systemic antibiotics within multimodal HS management.

Zitieren

APA

Rosi, E., Silvi, G., Cesare, A. D., Krajewski, P. K., Szepietowski, J., Denofre, A. T., Magalhães, R. F., Bettoli, V., Pelucchi, C., Galeone, C., & Prignano, F. (2026). Real-world systemic antibiotic prescribing patterns in hidradenitis suppurativa: a multicentre international observational study. Dermatology. https://doi.org/10.1159/drm/ackag033

Vancouver

Rosi E, Silvi G, Cesare AD, Krajewski PK, Szepietowski J, Denofre AT, et al. Real-world systemic antibiotic prescribing patterns in hidradenitis suppurativa: a multicentre international observational study. Dermatology. 2026. doi:10.1159/drm/ackag033

BibTeX
@article{Rosi2026,
  author = {Rosi, Elia and Silvi, Gianmarco and Cesare, Antonella Di and Krajewski, Piotr K and Szepietowski, Jacek and Denofre, Ariany T.A.S. and Magalhães, Renata Ferreira and Bettoli, Vincenzo and Pelucchi, Claudio and Galeone, Carlotta and Prignano, Francesca},
  title = {Real-world systemic antibiotic prescribing patterns in hidradenitis suppurativa: a multicentre international observational study},
  journal = {Dermatology},
  year = {2026},
  doi = {10.1159/drm/ackag033}
}
Kostenlos starten →